Search the Newsreel

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?

Stryker Corporation SYK shares have risen 13.6% in the past three months, outpacing the Zacks Medical sector's 12.9% gain and the S&P 500's 1.7% advance. The move has coincided with a sharper operating recovery after a difficult first quarter. The investor question is whether …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?

Stryker (NYSE:SYK) turned in one of its stronger quarters in recent memory on July 30, with sales climbing 9.4% to $6.6 billion and reported EPS jumping 44.1% to $3.30. The numbers arrive as the company works its way back from a cyber incident that …

Projeções de Resultados: Stryker Corp (SYK) — LPA e Crescimento de Receita

Stryker declares an $0.88 per share quarterly dividend

Stryker Corporation Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable October 30, 2026, to shareholders of record at the close of business on September 30, 2026, …

Solventum (SOLV) Appoints Neil Zieselman As New Chief Accounting Officer

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting …

Is Stryker (SYK) Undervalued As Earnings Trigger A Fresh Valuation Question?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Stryker (SYK) is back in focus after its second quarter 2026 earnings, reporting sales of US$6.59b and net income of US$1.28b, alongside a …

How Strong Q2 Earnings, Raised Guidance and Cyber Recovery Will Impact Stryker (SYK) Investors

Stryker Corporation's recently reported Q2 2026 results showed sales rising to US$6,589 million and net income to US$1,276 million, with both basic and diluted EPS from continuing operations increasing compared with the prior year period. Management also highlighted 9% organic sales growth, recovery progress …

SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion

SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion Medical technology company Stryker (NYSE:SYK) met Wall Street's revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share …

Why Stryker (SYK) Shares Are Plunging Today

Why Stryker (SYK) Shares Are Plunging Today What Happened? Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results that showed revenue that only met Wall Street's expectations and organic sales growth that missed forecasts. …

Stryker nets $6.6bn revenue in Q2; highlights resilience following cyberattack

Stryker has reported Q2 revenues of $6.6bn, denoting a 9.4% rise year-over-year (YoY), with the company's CEO lauding its "significant progress" in recovering since its global operations were disrupted by an cyberattack in March. Following the results, Stryker is tweaking its 2026 outlook at …

Stryker Corp (SYK) (Q2 2026) Earnings Call Highlights: Strong 9% Organic Growth and Raised ...

This article first appeared on GuruFocus. Organic Sales Growth: 9% for Q2 2026, against a double-digit comparable in Q2 2025. Adjusted EPS: $3.69, up 17.9% year-over-year. Adjusted Gross Margin: 66%, 60 basis points favorable to Q2 2025. Adjusted Operating Margin: 27.4% of sales, 170 …

Stryker expects 8.3%-9.3% organic sales growth and $14.95-$15.10 adjusted EPS in 2026 as it resumes share repurchases

Earnings Call Insights: Stryker (SYK) Q2 2026 MANAGEMENT VIEW * CEO Kevin Lobo said, "Our second quarter results demonstrated the strength of our broad product portfolio and resiliency of our teams," and added, "Our recovery from the cybersecurity incident continued as we ramped overall …

Stryker (SYK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2026, Stryker (SYK) reported revenue of $6.59 billion, up 9.4% over the same period last year. EPS came in at $3.69, compared to $3.13 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $6.56 …

Stryker (NYSE:SYK) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops

Stryker (NYSE:SYK) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops Medical technology company Stryker (NYSE:SYK) met Wall Street's revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share was …

Stryker reports second quarter 2026 operating results

Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026: Second Quarter Results Reported net sales increased9.4% to $6.6 billionOrganic net sales increased9.0%Reported operating income margin of 25.2%Adjusted operating income margin(1)increased170 bps to27.4%Reported EPS increased44.1% …

Stryker (SYK) Launches Mako RPS To Bring Robotic Knee Surgery To More Surgeons

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Stryker has introduced Mako RPS, a robotic handheld system for total knee replacement, expanding its Mako robotics portfolio. The launch extends robotic assistance to …

PAHC vs. SYK: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There …

Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS

Wall Street analysts expect Stryker (SYK) to post quarterly earnings of $3.46 per share in its upcoming report, which indicates a year-over-year increase of 10.5%. Revenues are expected to be $6.56 billion, up 8.9% from the year-ago quarter. Over the last 30 days, there …

Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point …